Journal of the American Heart Association · 2023 · 33 citations · 53 references
MedicineCardiologyCardiovascular GeneticsMetabolomicsPreventive CardiologyAtrial FibrillationCardiac BiomarkersCardiac Risk AssessmentCardiometabolic Risk ReductionCardiovascular DiseaseHeart FailureAtrial Fibrillation BiomarkersCardiometabolic DiseaseCardiovascular Risk MarkersCohort-based MetabolomicsFramingham Risk ScoreMetabolomic BiomarkersMetabolomic ChangesMetabolomic Signatures
Background The American Heart Association's framework "ideal cardiovascular health" (CVH) focuses on modifiable risk factors to reduce cardiovascular disease (CVD). Metabolomics provides important pathobiological insights into risk factors and CVD development. We hypothesized that metabolomic signatures associate with CVH status, and that metabolites, at least partially, mediate the association of CVH score with atrial fibrillation (AF) and heart failure (HF). Methods and Results We studied 3056 adults in the FHS (Framingham Heart Study) cohort to evaluate CVH score and incident outcomes of AF and HF. Metabolomics data were available in 2059 participants; mediation analysis was performed to evaluate the mediation of metabolites in the association of CVH score and incident AF and HF. In the smaller cohort (mean age, 54 years; 53% women), CVH score was associated with 144 metabolites, with 64 metabolites shared across key cardiometabolic components (body mass index, blood pressure, and fasting blood glucose) of the CVH score. In mediation analyses, 3 metabolites (glycerol, cholesterol ester 16:1, and phosphatidylcholine 32:1) mediated the association of CVH score with incident AF. Seven metabolites (glycerol, isocitrate, asparagine, glutamine, indole-3-proprionate, phosphatidylcholine C36:4, and lysophosphatidylcholine 18:2), partly mediated the association between CVH score and incident HF in multivariable-adjusted models. Conclusions Most metabolites that associated with CVH score were shared the most among 3 cardiometabolic components. Three main pathways: (1) alanine, glutamine, and glutamate metabolism; (2) citric acid cycle metabolism; and (3) glycerolipid metabolism mediated CVH score with HF. Metabolomics provides insights into how ideal CVH status contributes to the development of AF and HF.
53
Metabolite profiles and the risk of developing diabetes
Thomas J. Wang, Martin G. Larson, Ramachandran S. Vasan et al. · Nature Medicine · 2011 · 3.1K citations · Full text
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
William B. Kannel, Manning Feinleib, Patricia McNamara et al. · American Journal of Epidemiology · 1979 · 1.7K citations
Medicine, Cardiology, Epidemiology +12
Mediation Analysis with Multiple Mediators
Tyler J. VanderWeele, Stijn Vansteelandt · Epidemiologic Methods · 2014 · 899 citations · Full text